Guangdong Biolight Meditech Co Ltd (300246) - Total Liabilities
Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) has total liabilities worth CN¥1.28 Billion CNY (≈ $187.13 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Guangdong Biolight Meditech Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Guangdong Biolight Meditech Co Ltd - Total Liabilities Trend (2008–2025)
This chart illustrates how Guangdong Biolight Meditech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 300246 current and non-current assets.
Guangdong Biolight Meditech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Biolight Meditech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gladstone Commercial Corporation
NASDAQ:GOOD
|
USA | $915.44 Million |
|
Zhongyin Babi Food Co. Ltd.
SHG:605338
|
China | CN¥517.01 Million |
|
Gyre Therapeutics Inc.
NASDAQ:GYRE
|
USA | $25.03 Million |
|
Top Resource Conservation Engineering Co Ltd
SHE:300332
|
China | CN¥3.69 Billion |
|
ROX Resources Ltd
AU:RXL
|
Australia | AU$12.10 Million |
|
Shanghai Sunglow Packaging Technology Co Ltd Co Ltd Class A
SHG:603499
|
China | CN¥620.64 Million |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥247.79 Million |
|
Chengdu Xiling Power Science & Technology Incorporated Co Class A
SHE:300733
|
China | CN¥1.58 Billion |
Liability Composition Analysis (2008–2025)
This chart breaks down Guangdong Biolight Meditech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 300246 equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Biolight Meditech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Biolight Meditech Co Ltd (2008–2025)
The table below shows the annual total liabilities of Guangdong Biolight Meditech Co Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.31 Billion ≈ $191.71 Million |
+8.48% |
| 2024-12-31 | CN¥1.21 Billion ≈ $176.73 Million |
+5.44% |
| 2023-12-31 | CN¥1.15 Billion ≈ $167.62 Million |
+22.32% |
| 2022-12-31 | CN¥936.42 Million ≈ $137.03 Million |
+28.78% |
| 2021-12-31 | CN¥727.13 Million ≈ $106.40 Million |
+26.60% |
| 2020-12-31 | CN¥574.33 Million ≈ $84.04 Million |
+52.90% |
| 2019-12-31 | CN¥375.62 Million ≈ $54.96 Million |
+26.91% |
| 2018-12-31 | CN¥295.97 Million ≈ $43.31 Million |
+20.24% |
| 2017-12-31 | CN¥246.15 Million ≈ $36.02 Million |
+35.03% |
| 2016-12-31 | CN¥182.29 Million ≈ $26.68 Million |
+52.19% |
| 2015-12-31 | CN¥119.78 Million ≈ $17.53 Million |
+31.53% |
| 2014-12-31 | CN¥91.07 Million ≈ $13.33 Million |
+16.99% |
| 2013-12-31 | CN¥77.84 Million ≈ $11.39 Million |
+40.08% |
| 2012-12-31 | CN¥55.57 Million ≈ $8.13 Million |
+31.79% |
| 2011-12-31 | CN¥42.16 Million ≈ $6.17 Million |
+10.73% |
| 2010-12-31 | CN¥38.08 Million ≈ $5.57 Million |
+4.49% |
| 2009-12-31 | CN¥36.44 Million ≈ $5.33 Million |
+14.35% |
| 2008-12-31 | CN¥31.87 Million ≈ $4.66 Million |
-- |
About Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, el… Read more